University of Kentucky
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kentucky sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
University of Kentucky: 54 sponsored US clinical trials, 5 recruiting.
University of Kentucky sponsors 54 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 41 completed. 4 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Methamphetamine Abuse, with 2 trials.
Top-decile sponsor footprint
University of Kentucky ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
41 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
54 total, page 1 of 2
Recovery of Physical Function After Critical Illness In Older Adults
NCT07225257
Auditory Biofeedback Gait Training Individuals With Chronic Ankle Instability
NCT06868316
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
NCT05576350
Cannabis and Opioid Use Disorder
NCT05729932
OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
NCT06336122
Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy
NCT07594002
Cannabis and Opioid Use Disorder, Study 2
NCT07661446
Moringa Supplementation for Improved Milk Output
NCT05333939
Ultrasound High BMI Study
NCT05052658
Development of a Mind Body Program for Obese Knee Osteoarthritis Patients With Comorbid Depression
NCT04334278
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia
NCT04427527
Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19
NCT04412330
Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-stroke Hemiparesis
NCT04574973
Muscle Dysfunction in Critical Illness
NCT03717831
Adaptation and Pilot Testing of a Behavioral Parent Training Program for Parents of Deaf and Hard of Hearing Children
NCT03483428
Exercise and Weight Control
NCT03413826
Dysregulated CNS Inflammation After Acute Brain Injury
NCT03287557
The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation
NCT03164395
Brain Exercises for Synaptic Plasticity
NCT03058055
AT-001 for Long-term Preservation of Brain Health in Aging
NCT03062384
Peripheral Nerve Stimulation to Improve Upper Extremity Function After Severe Stroke
NCT04576013
Methylphenidate-Duloxetine Combinations for Cocaine Dependence
NCT02700711
A Pilot of Bystander Training Programming in Sexual Violence and Subtance Abuse
NCT02591212
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208
Assessing and Addressing Behaviors in Children With Hearing Loss
NCT02423746
Topiramate-Phentermine Combinations for Cocaine Dependence
NCT02239913
Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
NCT02048917
n-Acetylcysteine and Cocaine
NCT02141620
Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery
NCT02058862
Effects of Transvertebral Direct Current Stimulation in Humans
NCT04586777
Socket Preservation: A Clinical and Histological Study
NCT03422692
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
NCT01967381
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
NCT01883869
Buspirone as a Candidate Medication for Methamphetamine Abuse
NCT01843205
A Prospective Trial on the Effects of Vitamin D Supplementation in Collegiate Swimmers and Divers
NCT01488227
A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction
NCT01561287
The Effect of Nutrisystem Meal Provision on Weight
NCT01252303
A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies
NCT01202370
Trunk Strength Study
NCT01300936
Evaluation of Green Dot a Primary Prevention Intervention
NCT01878097
Effects of Selective Laser Trabeculoplasty
NCT00986141
Trichloroethylene (TCE) Exposure in an Industrial Population
NCT00839514
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NCT01690052
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273
Kinematics of Youth (Age 12-15) on Stationary All Terrain Vehicles
NCT00692029
Agonist Replacement Therapy for Cocaine Dependence
NCT00697138
A Prospective Study to Determine the Effectiveness of Reaming in Reducing Fat Emboli to the Lungs
NCT00327158
Study of Sutures Versus Staples for Skin Closure After Surgical Procedures of Hip
NCT00273715
Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer
NCT00237575
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
NCT00176293
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 2 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the University of Kentucky pipeline
5 recruiting of 54 indexed (9% open); 41 completed (76%).
Phase mix: 4 late (III/IV) vs 16 early (I/II) (early-phase heavy).
Top condition: Methamphetamine Abuse (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kentucky: open-pipeline peers nationwide
Peers matched on 54 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
University of Kentucky sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 trials (± recruiting share)
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
- Auburn University · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Shionogi · 9% recruiting · 54 trials
- University of Vermont · 9% recruiting · 162 trials
- Eli Lilly and Company · 9% recruiting · 1,341 trials
- Lahey Clinic · 9% recruiting · 43 trials
Related
What to do with this University of Kentucky page
54 registered trials is a research-attention snapshot, not an endorsement of University of Kentucky or any single study.
- 5 of University of Kentucky's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Methamphetamine Abuse is the condition University of Kentucky studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Methamphetamine Abuse trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Kentucky pipeline card: 54 registered trials from official public datasets.Report a data error.